Publications by authors named "Dennis Citrin"

Claim this Profile
P
Prolonged Self-Resolving Neutropenia Following Asymptomatic COVID-19 Infection.
Shreya Desai, Javairia Quraishi, Dennis Citrin

Cureus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular Pain and Mesenteric Adenitis as an Atypical Presentation of COVID-19.
Shreya Desai, Dennis Citrin, Mark Conneely

Cureus· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Patients With Lobular Breast Cancer Harboring Human Epidermal Growth Factor Receptor 2 Mutation With HER2-Directed Therapy.
Dennis L Citrin, Bradford A Tan, Nimesh B Patel, Vicki Doctor, Siraj M Ali

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
Denise A Yardley, Robert Weaver, Michelle E Melisko, Mansoor N Saleh, Francis P Arena, Dennis Citrin

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies.
Dennis L Citrin, Diane L Bloom, James F Grutsch, Sara J Mortensen, Christopher G Lis

Oncologist· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II open-label study of sunitinib in patients with advanced breast cancer.
Denise A Yardley, E Claire Dees, Stephen D Myers, Sherry Li, Paul Healey, Dennis L Citrin

Breast Cancer Res Treat· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
Stephen Johnston, Maureen Trudeau, Bella Kaufman, Hamouda Boussen, Kimberley Blackwell, Dennis L Citrin

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis